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Aims: The present meta-analysis aims to assess the evidence regarding the diagnostic
accuracy and performance characteristics of the colorimetric redox indicator (CRI) assay
with a special emphasis on the use of the resazurin microtiter assay (REMA) for determina-
tion of primary anti-tuberculosis drug resistance.
Subject and methods: By updating previous literature searches in Medline PubMed, ISI Web,
Web of Science and Google academic databases of the REMA test for determination of pri-
mary anti-tuberculosis drug resistance, this meta-analysis includes 14 studies for isoniazid
(INH); 15 studies for rifampicin (RIF); 6 studies for streptomycin (STR); and 5 studies for eth-
ambutol (EMB). SROC curve analysis was performed for meta-analysis and diagnostic accu-
racy was summarized.
Results: Pooled sensitivity was 96% (94–98%) for INH, 97% (95–98%) for RIF, 92% (87–96%) for
EMB and 92% (88–95%) for STR. Pooled specificity for INH, RIF, EMB and STR was 96% (95–
98%), 99% (98–99%), 86% (81–89%) and 90% (87–93%), respectively. Susceptibility testing
results had been obtained in 8–9 days.
Conclusion: In conclusion, REMA seems to be a reliable test for the determination of multi-
drug resistant (MDR) isolates in laboratories with limited resources. However, few studies
for STR and EMB have been found, and cost-effectiveness studies need to be determined
to recommend its widespread use.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.
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bidity and mortality worldwide [1]. The World Health Organi-
zation (WHO) reported that there were 8.7 million TB cases,
and 13% of these were co-infected with the human immuno-
deficiency virus (HIV) in 2011. It also reported that TB caused
1.4 million deaths [2]. Increased multi-drug resistant TB
(MDR-TB) cases threaten a more effective control of the dis-
ease [3]. Rapid and accurate identification of these resistant
cases is the most important step for preventing the spread
of MDR-TB isolates in the population. Conventional methods1 – Description of studies included in the meta-analysis o
rences Countries Reference test
t et al. [12] India PM on LJ
nga et al. [14] Uganda/Sweden PM on LJ
toro et al. [15] Cuba/Belgium PM on LJ
mino et al. [16] Belgium/Bolivia/Peru PM on LJ
tin et al. [10]
te 1 Belgium PM on LJ
te 2 Argentina PM on LJ
te 3 Cuba PM on LJ
te 4 Brazil PM on LJ
te 5 Colombia PM on LJ
te 6 Chile PM on LJ
te 7 Nicaragua PM on LJ
ire et al. [17] Madagascar/Belgium PM on LJ
labi et al. [18] Benin/Belgium/France PM on LJ
don et al. [19] Venezuela/USA PM on 7H10 agar
tin et al. [20] Belgium/Argentina/
Colombia/Sweden
PM on LJ
n et al. [11] Turkey Bactec 460 TB
ia et al. [21] Argentina PM on 7H11 agar
n et al. [22] Turkey Bactec 460 TB/MG
che et al. [23] Algeria/Belgium PM on LJ
et al. [24] Italy PM on 7H11 agar
Time to positivity.for drug susceptibility testing (DST) including proportion,
absolute concentration and resistant ratio methods are used
for identification of drug-resistant isolates. Rapid automated
systems (Bactec 460 TB and Bactec MGIT 960) are also avail-
able for this purpose [4,5]. However, obtaining DST results
on conventional Lo¨wenstein–Jensen or agar-based media
requires 3–6 weeks. Automated systems are faster, but
their high cost and need for equipment limit their use in
developing countries for early diagnosis and management of
MDR-TB [3].f INH resistance detection.
No.
isolates
Sensitivity
(95% CI)
Specificity
(95% CI)
TTP
(day)
105 0.93 (0.82–0.98) 0.98 (0.89–1.00) 8
31 0.88 (0.64–0.99) 0.57 (0.29–0.82) 8
100 1.00 (0.92–1.00) 0.96 (0.87–1.00) 8
80 1.00 (0.93–1.00) 0.96 (0.80–1.00) 8
30 1.00 (0.74–1.00) 1.00 (0.81–1.00) 8
30 1.00 (0.74–1.00) 1.00 (0.81–1.00) 8
30 1.00 (0.74–1.00) 0.94 (0.73–1.00) 8
30 1.00 (0.74–1.00) 0.94 (0.73–1.00) 8
30 1.00 (0.69–1.00) 1.00 (0.75–1.00) 8
30 0.92 (0.62–1.00) 1.00 (0.81–1.00) 8
30 0.92 (0.62–1.00) 0.94 (0.73–1.00) 8
77 0.95 (0.83–0.99) 0.97 (0.86–1.00) 8
151 1.00 (0.85–1.00) 1.00 (0.97–1.00) 8
155 0.79 (0.66–0.89) 0.96 (0.90–0.99) 8
149 0.99 (0.95–1.00) 1.00 (0.88–1.00) 8
50 1.00 (0.87–1.00) 0.92 (0.73–0.99) 8–9
69 1.00 (0.85–1.00) 0.94 (0.82–0.99) 8
IT 960 73 1.00 (0.89–1.00) 0.90 (0.77–0.97) 8
136 1.00 (0.80–1.00) 0.98 (0.94–1.00) 8
13 1.00 (0.48–1.00) 1.00 (0.63–1.00) 8
Fig. 1 – Forest plot of the sensitivity for INH assay. The point estimates of sensitivity from each study are shown as circles.
Error bars 95% confidence intervals.
Fig. 2 – Forest plot of the specificity for INH assay. The point estimates of specificity from each study are shown as circles.
Error bars 95% confidence intervals.
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Fig. 3 – Summary receiver operating characteristic (SROC) plot for INH. Each circle represents each study in the analysis. The
curve is the regression line that summarizes the overall diagnostic accuracy. SROC, summary receiver operating
characteristic; AUC, area under the curve; SE (AUC), standard error AUC; Q*, an index defined by the point on the SROC curve
where the sensitivity and specificity are equal, which is the point closest to the top-left corner of the ROC space; SE (Q*),
standard error of Q* index.
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formed synthesizing the evidence available on the accuracy
of the colorimetric method for detecting rifampicin (RIF)
and isoniazid (INH) resistance [3]. Evidence summarized in
that review did not include streptomycin (STR) or ethambutol
(EMB). Since 2007, there have been several new studies look-
ing not only at RIF and INH, but also all first-line drugs.
Resazurin microtiter assay (REMA), a rapid, reliable, inex-
pensive and easily performed colorimetric method, has
gained interest recently for the determination of MDR-TB.
Additionally, it is recommended among non-commercial
DST methods by the WHO [6].
The objective of this study was to update the previously
reported systematic review and meta-analysis of evidence
regarding the diagnostic accuracy and performance charac-
teristics of the REMA test for determination of primary anti-
tuberculosis drugs, including INH, RIF, EMB and STR resis-
tance, among Mycobacterium tuberculosis.
Materials and methods
Literature search
Medline PubMed, ISI Web, Web of Science and Google aca-
demic databases were searched using the keywords ‘‘resazu-rin’’ ‘‘resazurin microtiter assay’’, ‘‘resazurin assay’’,
‘‘colorimetric’’, ‘‘Mycobacterium tuberculosis’’, ‘‘tuberculosis’’,
‘‘drug susceptibility’’, ‘‘drug resistance’’, ‘‘isoniazid’’, ‘‘rifampi-
cin’’, ‘‘ethambutol’’ and ‘‘streptomycin’’. Studies published up
to June 2013 in English, French, or Spanish and those that met
the inclusion criteria were identified and were included in the
meta-analysis.
Inclusion criteria
Studies were included that compared REMA with a reference
method using a solid culture, such as Lo¨wenstein–Jensen or
Middlebrook 7H10/7H11 agar medium, or using a liquid cul-
ture, such as BACTEC MGIT 960, and studies that data could
be extracted with diagnostic accuracy. Studies reported in
conference abstract books were excluded.
Data extraction
The retrieved articles were reviewed by two independent
reviewers. Titles and abstracts of articles were read, and
eligible ones were marked for data extraction. Two review-
ers extracted data independently including author, year of
publication of the study, country in which the study was
performed, reference method used (indirect or direct),
Table 2 – Description of studies included in the meta-analysis of RIF resistance detection.
References Countries Reference
test
No.
isolates
Sensitivity
(%95 CI)
Specificity
(%95 CI)
TTP
(day)
Dixit et al. [12] India PM on LJ 105 0.95 (0.85–0.99) 1.00 (0.93–1.00) 8
Bwanga et al. [14] Uganda/Sweden PM on LJ 31 0.71 (0.42–0.92) 0.94 (0.71–1.00) 8
Montoro et al. [15] Cuba/Belgium PM on LJ 100 1.00 (0.91–1.00) 0.98 (0.91–1.00) 8
Palomino et al. [16] Belgium/Bolivia/Peru PM on LJ 80 1.00 (0.93–1.00) 1.00 (0.89–1.00) 8
Martin et al. [10]
Site 1 Belgium PM on LJ 30 1.00 (0.78–1.00) 1.00 (0.78–1.00) 8
Site 2 Argentina PM on LJ 30 1.00 (0.78–1.00) 1.00 (0.78–1.00) 8
Site 3 Cuba PM on LJ 30 0.93 (0.68–1.00) 1.00 (0.78–1.00) 8
Site 4 Brazil PM on LJ 30 1.00 (0.78–1.00) 1.00 (0.78–1.00) 8
Site 5 Colombia PM on LJ 30 1.00 (0.74–1.00) 1.00 (0.72–1.00) 8
Site 6 Chile PM on LJ 30 1.00 (0.78–1.00) 1.00 (0.78–1.00) 8
Site 7 Nicaragua PM on LJ 30 0.93 (0.68–1.00) 0.93 (0.68–1.00) 8
Rivoire et al. [17] Madagascar/Belgium PM on LJ 77 0.95 (0.75–1.00) 1.00 (0.94–1.00) 8
Affolabi et al. [18] Benin/Belgium/France PM on LJ 151 0.94 (0.70–1.00) 1.00 (0.97–1.00) 8
Rondon et al. [19] Venezuella/USA PM on 7H10 agar 155 0.80 (0.59–0.93) 0.98 (0.93–1.00) 8
Martin et al. [20] Belgium/Argentina/
Colombia/Sweden
PM on LJ 149 1.00 (0.97–1.00) 0.94 (0.81–0.99) 8
Coban et al. [11] Turkey Bactec 460 TB 50 1.00 (0.81–1.00) 1.00 (0.89–1.00) 8–9
Iglesia et al. [21] Argentina PM on 7H11 agar 69 1.00 (0.86–1.00) 0.98 (0.88–1.00) 8
Coban et al. [22] Turkey Bactec 460 TB/MGIT 960 73 0.91 (0.72–0.99) 1.00 (0.93–1.00) 8
Nateche et al. [23] Algeria/Belgium PM on LJ 136 1.00 (0.74–1.00) 0.99 (0.96–1.00) 8
Banfi et al. [24] Italy PM on 7H11 agar 13 1.00 (0,39–1.00) 1.00 (0.66–1.00) 9
Lemus et al. [25] Cuba/Belgium PM on LJ 20 1.00 (0.69–1.00) 1.00 (0.69–1.00) 8
TTP: Time to positivity.
Fig. 4 – Forest plot of the sensitivity for RIF analysis. The point estimates of sensitivity from each study are shown as circles.
Error bars 95% confidence intervals.
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obtaining results; all information gathered was then
entered into a datasheet of Microsoft Excel software. Dis-
agreements between reviewers were solved by consensus.
Sensitivity [true positive rate (TPR)] was defined as the pro-
portion of isolates determined to be resistant by the refer-
ence method and correctly identified as resistant by REMA.
Specificity [true negative rate (TNR)] was defined as the
proportion of isolates determined to be susceptible by the
reference method and correctly identified as susceptible
by REMA.
Meta-analysis
Meta-analysis was performed by using Meta-DiSc software
(version 1.4) [7]. It was focused on the sensitivity and spec-
ificity values for measurement of diagnostic accuracy of
the used test. A forest plot was created for estimating
the accuracy of the test. Receiver operating characteristic
(ROC) curves indicating the relationship between the TPR
and the false positive rate (FPR) of the test were also plot-
ted. The Q* index represents a summarization of the test
performance where sensitivity and specificity are equal.
The heterogeneity X2 and I2 indexes were used for analyz-
ing the heterogeneity among studies used for meta-
analysis.Fig. 5 – Forest plot of the specificity for RIF analysis. The point e
Error bars 95% confidence intervals.Quality assessment
The quality of individual studies was assessed by using crite-
ria based on the QUADAS tools for the assessment of quality
of diagnostic studies [8].
Reporting bias
Publication bias using methods such as funnel plots or regres-
sion tests were not performed in this review because such
techniques have not been found to be helpful for diagnostic
studies [9].
Results
Detection of INH resistance
Data including country in which the study was performed, ref-
erence method used in the study, number and type of samples,
sensitivity and specificity values and time for obtaining results
in which REMA was used for determination of INH resistance
are summarized in Table 1. Fourteen studies were included
and analyzed. One study [10] was performed in 7 different cen-
ters, so the results of each center are presented individually in
Table 1. REMA was performed as an indirect test among clini-
cal isolates in all studies. The reference test was the propor-stimates of specificity from each study are shown as circles.
Fig. 6 – Summary receiver operating characteristic (SROC) plot for RIF. Each circle represents each study in the analysis. The
curve is the regression line that summarizes the overall diagnostic accuracy. SROC, summary receiver operating
characteristic; AUC, area under the curve; SE (AUC), standard error AUC; Q*, an index defined by the point on the SROC curve
where the sensitivity and specificity are equal, which is the point closest to the top-left corner of the ROC space; SE (Q*),
standard error of Q* index.
Table 3 – Description of studies included in the meta-analysis of EMB resistance detection.
References Countries Reference test No. isolates Sensitivity (%95 CI) Specificity (%95 CI) TTP (day)
Dixit et al. [12] India PM on LJ 105 0.84 (0.71–0.92) 0.94 (0.83–0.99) 8
Montoro et al. [15] Cuba/Belgium PM on LJ 100 0.94 (0.71–1.00) 0.58 (0.46–0.69) 8
Martin et al. [10]
Site 1 Belgium PM on LJ 30 0.89 (0.52–1.00) 0.95 (0.76–1.00) 8
Site 2 Argentina PM on LJ 30 1.00 (0.66–1.00) 1.00 (0.84–1.00) 8
Site 3 Cuba PM on LJ 30 1.00 (0.66–1.00) 0.95 (0.76–1.00) 8
Site 4 Brazil PM on LJ 30 1.00 (0.66–1.00) 0.95 (0.76–1.00) 8
Site 5 Colombia PM on LJ 30 1.00 (0.63–1.00) 1.00 (0.78–1.00) 8
Site 6 Chile PM on LJ 30 1.00 (0.66–1.00) 1.00 (0.84–1.00) 8
Site 7 Nicaragua PM on LJ 30 0.89 (0.52–1.00) 0.90 (0.68–0.99) 8
Banfi et al. [24] Italy PM on 7H11 agar 13 1.00 (0.39–1.00) 1.00 (0.66–1.00) 9
Jadaun et al. [26] India PM on LJ 50 0.97 (0.83–1.00) 1.00 (0.82–1.00) 8–9
TTP: Time to positivity.
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ies; Bactec 460 TB in 2 studies; PM on 7H11 agar in 2 studies; PM
on 7H10 agar in 1 study; and MGIT 960 in 1 study.
REMA was performed in microtiter plates in 13 of 14 stud-
ies, whereas it was performed in tubes with screw caps as a
macro test in one study [11]. Furthermore, the test was per-
formed in albumin-containing Dubos broth in 1 study; in7H9 broth in 3 studies; and 7H9-S (with 0.1% casitone) broth
in the remaining 10 studies.
Figs. 1 and 2 illustrate forest plots that estimate the sensi-
tivity and specificity based on results of the 14 included stud-
ies. Fig. 3 is an SROC curve of the same data. Sensitivity was
determined as 88–100% and specificity was reported as
57–100% (Table 1, Figs. 1 and 2). The SROC curve shows an
Fig. 7 – Forest plot of the sensitivity for EMB. The point estimates of sensitivity from each study are shown as circles. Error
bars 95% confidence intervals.
Fig. 8 – Forest plot of the specificity for EMB. The point estimates of specificity from each study are shown as circles. Error bars
95% confidence intervals.
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accuracy (Fig. 3).
Detection of RIF resistance
Results of studies in which REMA was used for determination
of RIF resistance are summarized in Table 2. Fifteen studies
were analyzed. Results were evaluated individually and are
presented in Table 2. All studies evaluated the test with clin-
ical isolates. The reference method was PM on LJ medium in
10 studies; Bactec 460 TB in 1 study; both Bactec 460 TB and
Bactec MGIT 960 in 1 study; PM on 7H10 agar in 1 study; and
PM on 7H11 agar in 2 studies.
REMA was performed in microtiter plates in 14 of 15
analyzed studies, whereas it was performed as a macro testin tubes with a screw cap in 1 study. It was also performed
in albumin-containing Dubos broth in 1 study; in 7H9 broth
in 3 studies; and in 7H9-S broth in the remaining 10
studies.
Figs. 4 and 5 illustrate forest plots that estimate the sensi-
tivity and specificity based on results of the 14 included stud-
ies. Fig. 6 is an SROC curve of the same data. Sensitivity was
determined as 71–100% and specificity was 93.3–100% (Table 2,
Figs. 4 and 5). The SROC curve shows an AUC of 0.99 and Q* of
0.96, indicating a high level of overall accuracy (Fig. 6).
Detection of EMB resistance
Results of studies in which REMA was used for determination
of EMB resistance are summarized in Table 3. Only 5 studies
Fig. 9 – Summary receiver operating characteristic (SROC) plot for EMB. Each circle represents each study in the analysis. The
curve is the regression line that summarizes the overall diagnostic accuracy. SROC, summary receiver operating
characteristic; AUC, area under the curve; SE (AUC), standard error AUC; Q*, an index defined by the point on the SROC curve
where the sensitivity and specificity are equal, which is the point closest to the top-left corner of the ROC space; SE (Q*),
standard error of Q* index.
Table 4 – Description of studies included in the meta-analysis of STR resistance detection.
References Countries Reference test No. isolates Sensitivity (%95 CI) Specificity (%95 CI) TTP (day)
Dixit et al. [12] India PM on LJ 105 0.87 (0.76–0.95) 0.96 (0.86–1.00) 8
Montoro et al. [15] Cuba/Belgium PM on LJ 100 0.94 (0.83–0.99) 0.88 (0.77–0.96) 8
Martin et al. [10]
Site 1 Belgium PM on LJ 30 0.83 (0.52–0.98) 0.72 (0.47–0.90) 8
Site 2 Argentina PM on LJ 30 1.00 (0.74–1.00) 0.83 (0.59–0.96) 8
Site 3 Cuba PM on LJ 30 0.92 (0.62–1.00) 0.78 (0.52–0.94) 8
Site 4 Brazil PM on LJ 30 0.75 (0.43–0.95) 1.00 (0.81–1.00) 8
Site 5 Colombia PM on LJ 30 1.00 (0.66–1.00) 0.79 (0.49–0.95) 8
Site 6 Chile PM on LJ 30 0.92 (0.62–1.00) 0.83 (0.59–0.96) 8
Site 7 Nicaragua PM on LJ 30 0.92 (0.62–1.00) 0.83 (0.59–0.96) 8
Rondo´n et al. [19] Venezuella/USA PM on 7H10 agar 155 0.92 (0.82–0.97) 0.96 (0.89–0.99) 8
Iglesia et al. [21] Argentina PM on 7H11 agar 69 1.00 (0.82–1.00) 0.94 (0.83–0.99) 8
Banfi et al. [24] Italy PM on 7H11 agar 13 1.00 (0.54–1.00) 1.00 (0.59–1.00) 9
TTP: Time to positivity.
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test was performed as an indirect test with clinical isolates in
all studies. PM on LJ was used as a reference test in 4 studies
and PM on 7H11 agar in 1 study.
The test was performed in microtiter plates in all studies,
and 7H9-S and 7H9 broth were used as media for the test in 4
and 1 study, respectively.Figs. 7 and 8 illustrate forest plots that estimate the sensitiv-
ity and specificity based on results of the 4 included studies.
Fig. 9 is a SROC curve of the same data. Sensitivity was 83.64–
100%. However, the specificity was determined to be lower than
for RIF and INH with a pooled specificity of 85%. Specificity was
determined as 57.8–100% (Table 4, Figs. 7 and 8). The SROC
curve shows an AUC of 0.96 and Q* of 0.91 (Fig. 9).
Fig. 10 – Forest plot of the sensitivity for STR. The point estimates of sensitivity from each study are shown as circles. Error
bars 95% confidence intervals.
Fig. 11 – Forest plot of the specificity for STR. The point estimates of specificity from each study are shown as circles. Error
bars 95% confidence intervals.
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Six studies were analyzed for STR and are summarized in
Table 4 individually. The test was performed as an indirect
test among clinical isolates in all studies. The reference test
was PM on LJ medium in 3 studies; PM on 7H10 agar in 1
study; and PM on 7H11 agar in 2 studies.
The REMA was performed in microtiter plates in all ana-
lyzed studies. It was also performed in 7H9-S broth in 4 stud-
ies and 7H9 broth in the remaining 2 studies.
Figs. 10 and 11 illustrate forest plots that estimate the
sensitivity and specificity based on results of the 5 included
studies. Fig. 12 is a SROC curve of the same data. Sensitivity
was 75–100% and specificity was 72.2–100% (Table 4, Figs. 10
and 11). The SROC curve shows an AUC of 0.96 and Q* of
0.91 (Fig. 12).The results were obtained in 8–9 days in all analyzed
studies.
Discussion
One of the most important steps for better control of TB is the
rapid determination of drug resistance and implementation
of appropriate treatment [2,12]. There has been an increased
interest in developing rapid, reliable and low-cost methods
for this purpose. Colorimetric REMA is one of the proposed
methods developed for this purpose.
This meta-analysis was aimed at evaluating REMA, which
is a rapid, reliable and inexpensive method that gained an
increased interest for the determination of primary anti-
tuberculosis drug resistance. The results obtained indicate
that the test has a high reliability for the determination of
Fig. 12 – Summary receiver operating characteristic (SROC) plot for STR. Each circle represents each study in the analysis. The
curve is the regression line that summarizes the overall diagnostic accuracy. SROC, summary receiver operating
characteristic; AUC, area under the curve; SE (AUC), standard error AUC; Q*, an index defined by the point on the SROC curve
where the sensitivity and specificity are equal, which is the point closest to the top-left corner of the ROC space; SE (Q*),
standard error of Q* index.
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obtained for EMB and STR. No definitive conclusions can be
drawn for the latter two drugs since the number of published
studies is still too low.
REMA was performed only indirectly among M. tuberculosis
isolates grown in cultures, and as far as this research is con-
sidered, there is no study in which the test has been per-
formed directly in sputum samples to detect drug resistance.
One meta-analysis on colorimetric redox indicator assays
including REMA was found in the literature [3]. This previous
meta-analysis evaluated the test only for determination of
resistance to INH and RIF in 2007. It also analyzed the use of
other indicators such as MTT or Alamar blue. That analysis
included 6 studies using resazurin for INH and 7 for RIF [3].
The current meta-analysis is the first one specifically evaluat-
ing the REMA test for determination of all primary anti-tuber-
culosis drugs (INH, RIF, EMB and STR). The use of resazurin
has become more frequent due to its low cost for viability test-
ing. Moreover, the overall quality of the included studies was
very good according to the analysis performed with the QUA-
DAS tool.
The document ‘‘Noncommercial culture and drug sus-
ceptibility testing methods for screening patients at riskfor multidrug-resistant tuberculosis’’ published by WHO
defines that colorimetric redox indicator (CRI) assays like
REMA can be used for the determination of drug resis-
tance, but they are not faster than conventional pheno-
typic susceptibility tests performed in liquid media [6].
REMA, however, is much cheaper than phenotypic com-
mercial methods. The cost of this method is estimated at
approximately $3 for each strain tested against several
drugs [13].
In conclusion, this meta-analysis showed that the REMA
test is a reliable method for the detection of resistance to
INH and RIF and has acceptable sensitivity and specificity
for EMB and STR. However, more studies are needed to fully
recommend its wide use.
Therefore, REMA can be used for early detection of MDR-
TB cases, particularly in low-income countries due to its low
cost and simple technology.Conflict of interest
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